Deep brain stimulation for Parkinson's disease (IPG19)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 November 2003
Deep brain stimulation for tremor and dystonia (excluding Parkinson's disease) (IPG188)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 August 2006
Devices for remote monitoring of Parkinson’s disease (DG51)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 25 January 2024Published: 25 January 2023
Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms (TA934)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 29 November 2023
Parkinson’s disease in adults (NG71)Product type:GuidanceProgramme:NICE guidelinePublished: 19 July 2017
Selective peripheral denervation for cervical dystonia (IPG80)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 August 2004
Subthalamotomy for Parkinson's disease (IPG65)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 June 2004
Suspected neurological conditions: recognition and referral (NG127)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 1 May 2019
Unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson’s disease (IPG606)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 February 2018
Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor (IPG617)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 20 June 2018
Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea (TA605)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 9 October 2019